Combination antibiotics for blood staph infection
Part of Infections clinical trials.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are currently in the hospital at an Intermountain Health facility.
- You have a positive blood culture for a type of staph bacteria (either MRSA or MSSA).
- The blood culture was taken during this hospital stay, or within 48 hours before you came to the hospital, or within 24 hours before you were transferred to an Intermountain hospital.
- You agree to allow your medical information to be used in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving two antibiotics early, instead of the usual one, improves recovery for people with a staph bloodstream infection (a serious bacterial infection in the blood). If you qualify, participation will involve close monitoring and follow-up care.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This trial compares two antibiotics, vancomycin and daptomycin, to see which works better for treating MRSA bacteria in the blood. Patients are randomly assigned to one of the drugs and will be monitored closely for results and side effects.
This Phase 2 study tests whether adding ertapenem to cefazolin can improve treatment of staphylococcus (“S. aureus”) bloodstream infection that is likely methicillin-susceptible (MSSA). It aims to start the right antibiotics quickly, before MRSA status is fully confirmed, using early testing and a treatment plan guided by infectious-disease specialists.
This trial tests whether adding clopidogrel, a blood thinner, to standard care can help treat staph bloodstream infections. It may reduce the risk of complications, but it is only for patients who can take oral medications and are not at high risk of bleeding.
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
Hear when a new Staphylococcus Aureus Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.